The relative quiescence of hematopoietic stem cells in nonhuman primates

Citation
N. Mahmud et al., The relative quiescence of hematopoietic stem cells in nonhuman primates, BLOOD, 97(10), 2001, pp. 3061-3068
Citations number
64
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
97
Issue
10
Year of publication
2001
Pages
3061 - 3068
Database
ISI
SICI code
0006-4971(20010515)97:10<3061:TRQOHS>2.0.ZU;2-1
Abstract
Quiescence has been thought to be required for the retention of the full bi ological potential of pluripotent hematopoietic stem cells (PHSCs). This hy pothesis has been challenged recently by the observation that all murine PH SCs cycle continuously and constantly contribute to steady-state blood cell production. It was asked whether these observations could be extrapolated to describe hematopoiesis in higher mammals. In this series of experiments, the replicative history of PHSCs was examined in baboons by continuously a dministering bromodeoxyuridine (BrdU) for more than 85 weeks. The results i ndicate that under steady-state conditions, PHSCs remain largely quiescent but do cycle, albeit at a far lower rate than previously reported for roden t PHSCs. BrdU-labeled cycling PHSCs and progenitor cells were shown to have an extensive proliferative capacity and to contribute to blood cell produc tion for prolonged periods of time. The proportion of PHSCS entering cell c ycle could, however, be rapidly increased by the in vivo administration of granulocyte-colony stimulating factor. These data indicate that during stea dy-state hematopoiesis, baboon PHSCs require prolonged periods of time to c ycle and that the proportion of PHSCs in cycle is not fixed but can be alte red by external stimuli. The relative quiescence of PHSCs observed in this nonhuman primate model, in contrast to murine PHSCs, might explain the curr ent barriers to genetic modification and ex vivo expansion of human PHSCs. (Blood. 2001;97:3061-3068) (C) 2001 by The American Society of Hematology.